Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

Wenyue Cao, Jia Wei, Na Wang, Hao Xu, Min Xiao, Lifang Huang, Yang Cao, Chunrui Li, Yi Xiao, Chaojiang Gu, Shangkun Zhang, Dengju Li, Yichen Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang

Blood (2020) 136 (4): 516–519.

https://doi.org/10.1182/blood.2020004907

Published: 2020

Includes: Supplemental data

Journal Articles

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Asmaa Atteya, MD, Aiman Ahmad, MD, Dima Daghstani, BSC, Mohamed A Yassin, MBBS, MSc

Blood (2019) 134 (Supplement_1): 1648.

https://doi.org/10.1182/blood-2019-121834

Published: 2019

Journal Articles

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Wei Liu, Rui Lv, Wenyang Huang, Hong Liu, Shuhui Deng, MD, Shuhua Yi, MD, Lulu Lv, Jianxiang Wang, MD, Lugui Qiu, MD PhD, Dehui Zou, MD

Blood (2019) 134 (Supplement_1): 2913.

https://doi.org/10.1182/blood-2019-126635

Published: 2019

Journal Articles

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Huai-Hsuan Huang, Fei-Yuan Hsiao, PhD Associate Professor, Ho-Min Chen, M.S., Chen-Yu Wang, PhD, Hwei-Fang Tien, MD, PhD, Bor-Sheng Ko, MD PhD

Blood (2019) 134 (Supplement_1): 4765.

https://doi.org/10.1182/blood-2019-127972

Published: 2019

Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Blood (2018) 132 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2018-99-114850

Published: 2018

Journal Articles

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hua Yin, Suli Wang, Xingyu Lu, Wenyi Shen, MD, Ruinan Lu, Yu Zhu, MD PhD, Kourong Miao, Ming Hong, MD PhD, Shuai Wang, MD PhD, Jianfu Zhang, Chun Qiao, Yujie Wu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2018-99-118836

Published: 2018

Journal Articles

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

Chieh-Lung Cheng, MD, Erin Huang, Ming-Kai Chuang, MD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 4235.

https://doi.org/10.1182/blood-2018-99-114982

Published: 2018

Journal Articles

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Jieun Uhm, MD PhD, Sung-Hyun Kim, MD PhD, Sukjoong Oh, MD PhD, Dae Young Zang, MD PhD, Young Rok Do, PhD MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Sung-Eun Lee, MD PhD, Dong-Wook Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3010.

https://doi.org/10.1182/blood-2018-99-117543

Published: 2018

Journal Articles

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

Shigeru Kusumoto, MD, Luca Arcaini, MD, Xiaonan Hong, Jie Jin, Won Seog Kim, MD, Ph. D., Yok Lam Kwong, Marion Peters, Yasuhito Tanaka, Andrew D. Zelenetz, MD PhD, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2823.

https://doi.org/10.1182/blood.V130.Suppl_1.2823.2823

Published: 2017

Journal Articles

HBV Care Map for Patients Receiving Anti-CD20 Therapy

Zachary Liederman, MD, Neil Berinstein, MD, Michael Crump, MD, Jessica Hwang, MD MPH, Harry L.A. Janssen, PhD MD, C. Tom Kouroukis, MDMSc,FRCPC, Patricia Leung, Anna Lok, MD, Colina Yim, Andrew D. Zelenetz, MD PhD, Kelvin Chan, MD PhD, Jordan Feld, MD MPH, Lisa K. Hicks, MD MSc

Blood (2017) 130 (Supplement 1): 4697.

https://doi.org/10.1182/blood.V130.Suppl_1.4697.4697

Published: 2017

Journal Articles

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Blanca Sanchez-Gonzalez, MD PhD, Montserrat Garcia-Retortillo, MD PhD, Teresa Murcia, PhD, Mariana Ferraro, MD, Francesc Garcia-Pallarols, BSc, Dolors Gimenez, Sara Montesdeoca, Eva Gimeno, MD PhD, Eugenia Abella, MD PhD, Ricard Sola, MD PhD, Carlos Besses, MD PhD, Antonio Salar, MD PhD

Blood (2016) 128 (22): 1801.

https://doi.org/10.1182/blood.V128.22.1801.1801

Published: 2016

Journal Articles

A Comparison of Lamivudine and Entecavir for the Prophylaxis of Hepatitis B Virus Reactivation in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institutional Experience

Jin Shang, Jing Sun, MD, Zhiping Fan, Fen Huang, Yu Zhang, MD, Qianli Jiang, MD PhD, Hongsheng Zhou, Qifa Liu, MD

Blood (2015) 126 (23): 2026.

https://doi.org/10.1182/blood.V126.23.2026.2026

Published: 2015

Journal Articles

Screening and Management of Hepatitis B Virus before the First Rituximab Infusion: We Must Do Better!

Virginie Masse, MD, Ahmad Al Jijakli, MD, Philippe Genet, MD, Théodora Guerekobaya, Laurence Courdavault, MD, Fréderique Plassart, PharmD, Driss Chaoui, MD, Laurent Sutton, MD

Blood (2014) 124 (21): 2754.

https://doi.org/10.1182/blood.V124.21.2754.2754

Published: 2014

Journal Articles

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Qingqing Cai, MD PhD, Kailin Chen, MD, Qirong Geng, MD, Guangzheng Zhong, MD, Jianping Li, MD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Wenqi Jiang, MD PhD, Zhiming Li, MD PhD

Blood (2014) 124 (21): 1655.

https://doi.org/10.1182/blood.V124.21.1655.1655

Published: 2014

Journal Articles

Entecavir Is Safe and Effective As Prophylaxis for Reactivation of Hepatitis B Virus in Allogeneic Stem Cell Transplant Recipients with Chronic or Resolved Viral Hepatitis B Infection

Masanori Tsuji, MD, Hikari Ota, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Kazuhiro Masuoka, MD, PhD, Atsushi Wake, MD, PhD, Shigeyoshi Makino, MD, PhD, Akiko Yoneyama, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2012) 120 (21): 4144.

https://doi.org/10.1182/blood.V120.21.4144.4144

Published: 2012

Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 2641.

https://doi.org/10.1182/blood.V120.21.2641.2641

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy

Yongxian Hu, Yi Luo, Yamin Tan, Xiaoyu Lai, Jimin Shi, Jingsong He, Gaofeng Zheng, Weiyan Zheng, Wanzhuo Xie, Zhen Cai, He Huang

Blood (2011) 118 (21): 1949.

https://doi.org/10.1182/blood.V118.21.1949.1949

Published: 2011

Journal Articles

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

Blood (2010) 116 (21): 4911.

https://doi.org/10.1182/blood.V116.21.4911.4911

Published: 2010

Journal Articles

Prospective Analysis of Hepatitis B Virus Reactivation In Patients with Diffuse Large B Cell Lymphoma After Rituximab Combination Chemotherapy

Nozomi Niitsu, MD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Miyuki Hayama, MD, PhD, Naoki Takahashi

Blood (2010) 116 (21): 3950.

https://doi.org/10.1182/blood.V116.21.3950.3950

Published: 2010

Journal Articles

Hepatitis B Virus Reactivation in Malignant Lymphoma with Occult HBV Carrier.

Noriyasu Fukushima, Toshihiko Mizuta, Chisako Urata, Mariko Tanaka, Masako Yokoo, Masaru Ide, Takashi Hisatomi, Eisaburo Sueoka, Shinya Kimura, MD, PhD

Blood (2009) 114 (22): 4794.

https://doi.org/10.1182/blood.V114.22.4794.4794

Published: 2009

NARROW

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Standard Chemoimmunotherapy

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

HBV Care Map for Patients Receiving Anti-CD20 Therapy

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

A Comparison of Lamivudine and Entecavir for the Prophylaxis of Hepatitis B Virus Reactivation in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institutional Experience

Screening and Management of Hepatitis B Virus before the First Rituximab Infusion: We Must Do Better!

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Entecavir Is Safe and Effective As Prophylaxis for Reactivation of Hepatitis B Virus in Allogeneic Stem Cell Transplant Recipients with Chronic or Resolved Viral Hepatitis B Infection

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

Prospective Analysis of Hepatitis B Virus Reactivation In Patients with Diffuse Large B Cell Lymphoma After Rituximab Combination Chemotherapy

Hepatitis B Virus Reactivation in Malignant Lymphoma with Occult HBV Carrier.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only